![]() This test is for individuals who decide to pay out-of-pocket for the test and do not wish to have their claims submitted for reimbursement to their health plan or the government. The test is designed to detect antibodies in a blood sample that would indicate that a patient may have had a prior or recent COVID-19 infection. *Pricing is comprised of $199.00 for testing and conveyance of results, plus $6.00 for independent physician oversight of lab testing including ordering testing if appropriate, and providing physician follow-up services *Pricing is comprised of $119.00 for testing and conveyance of results, plus $5.50 for electronic order review by an authorized third-party provider ![]() The test is designed to detect the virus that causes COVID-19 in respiratory specimens. Quest will bill your health plan $925.65 c This is a multitarget molecular test that aids in simultaneous qualitative detection and differentiation of COVID-19, influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA among symptomatic patients. SARS-CoV-2 RNA (COVID-19), Influenza A/B, and RSV RNA, Qualitative NAAT Quest will bill your health plan $511.70 c This is a qualitative multi-target molecular diagnostics test that aids in simultaneous detection of COVID-19, influenza A and influenza B. ![]() SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT Quest will bill your health plan $110.00 c IgM antibodies to COVID-19 are generally detectable in blood several days after initial infection, with IgG antibodies typically reaching detectable levels simultaneously or 1-2 days later. The test is designed to detect IgG and IgM antibodies in a blood sample that may indicate exposure to COVID-19. SARS-CoV-2 Serology (COVID-19) Antibodies (IgG, IgM), Immunoassay Quest will bill your health plan or the government $55.00 c This test may detect an immune response to a prior or recent infection with SARS-CoV-2 (COVID-19). SARS-CoV-2 Antibody (IgG), Spike, Semi-Quantitative test Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider when billed to a health plan or the government Quest will bill your health plan or the government $100.00 or $125.00 depending on the plan The test is designed to detect the virus that causes COVID-19 in respiratory specimens, for example, nasal or oral swabs. SARS-CoV-2 RNA (COVID-19), Qualitative NAAT b
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |